Tuesday, May 30, 2023
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
    • Rewind
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
  • Rewind
Home | Business | Brazilian Govts 20 Million Dose Order Is Still Active Bharat Biotech

Brazilian govt’s 20 million dose order is still active: Bharat Biotech

"The agreement with Precisa Medicamentos is based on a long term partnership and will continue,” Bharat Biotech stated.

By Telangana Today
Published Date - 09:23 PM, Wed - 31 March 21
Brazilian govt’s 20 million dose order is still active: Bharat Biotech
Representational Image.
whatsapp facebook twitter telegram

Hyderabad: Following the denial of certificate for good manufacturing practices (GMP) by the Brazilian Health Regulatory Agency (Anvisa) to Bharat Biotech’s Covaxin (Covid-19 vaccine), the Hyderabad-based vaccine maker said, the requirements pointed out during inspection will be fulfilled, the timelines for fulfilment is under discussion with the Brazil National Regulatory Authority and will be resolved soon.

“The 20 million dose order from the Brazilian government is still active. The agreement with Precisa Medicamentos is based on a long term partnership and will continue,” the company stated.

“Considering the non-compliance with the requirements of Good Manufacturing Practices for Medicines, or the non-compliance with the petition procedures submitted for analysis, advocated by current legislation, resolves: Refuse the Request (s) for Certification of Good Manufacturing Practices for Medicines of the company (ies) contained in the ANNEX,” a Brazilian government gazette said on March 29.

Bharat Biotech signed an agreement with Brazil’s Health Ministry in the last week of February for supply of 20 million doses of Covaxin. The value of the deal is estimated at around Rs 2,140 crore ($1.6 billion Brazilian real). The delivery of Covaxin was scheduled during the second and third quarters of 2021.

The vaccine maker had applied for emergency use of Covaxin in Brazil on March 8. Anvisa’s approval is a necessary step for Brazil’s process of allowing the vaccine for emergency use. Covaxin is one of the two vaccines currently being administered in India. Brazil is the second-worst Covid-19-affected nation globally, in terms of mortality, after the US.

In the first interim analysis of Covaxin released by Bharat Biotech early March, the company said, the vaccine candidate demonstrated an interim vaccine efficacy of 81 per cent in its Phase 3 clinical trial. The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with the Indian Council of Medical Research.

Also Read:

Bharat Biotech signs deal with Brazil to supply Covaxin


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


  • Follow Us :
  • Tags
  • 20 million dose order
  • Bharat Biotech
  • Bharat Biotech’s Covaxin
  • Brazilian govt

Related News

  • Genome Valley: Home to Asia’s largest life sciences cluster

    Genome Valley: Home to Asia’s largest life sciences cluster

  • Krishna Ella releases book on ‘Economics of Covid-19’

    Krishna Ella releases book on ‘Economics of Covid-19’

  • India’s first intranasal Covid vaccine iNNCOVACC launched

    India’s first intranasal Covid vaccine iNNCOVACC launched

  • First Made-in-India intranasal Covid vaccine to be launched on R-Day

    First Made-in-India intranasal Covid vaccine to be launched on R-Day

  • Bharat Biotech’s intranasal Covid-19 vaccine to cost Rs 800 for private, 325 for govt hospitals

    Bharat Biotech’s intranasal Covid-19 vaccine to cost Rs 800 for private, 325 for govt hospitals

  • Editorial: Boost for vaccine coverage

    Editorial: Boost for vaccine coverage

Latest News

  • Hyderabad: Truck driver killed in road crash

    56 seconds ago
  • Go skydiving indoors at Gravity Zip for an exhilarating experience 

    6 mins ago
  • Canada accepts TOEFL iBT under Student Direct Stream scheme

    15 mins ago
  • #VS11 Rags look: Vishwak Sen and Sithara Entertainments pay a tribute to legendary NTR

    18 mins ago
  • Indian Railways announces five special summer trains; check routes

    27 mins ago
  • Eat good, feel good: Healthy cafés to visit in Hyderabad

    47 mins ago
  • SICA conducts two-day Foundation day concerts with Nisha Rajagopalan

    53 mins ago
  • ‘Takkar’ has unique love story with lot of action and romance: Siddharth

    53 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam